$1.52 Billion is the total value of Novo Holdings A/S's 47 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASML | ASML HOLDING N V | $154,364,607 | +24.6% | 226,770 | 0.0% | 10.18% | +31.7% | |
| CRM | SALESFORCE.COM, INC. | $115,572,730 | +50.7% | 578,500 | 0.0% | 7.62% | +59.2% | |
| CYT | CYTEIR THERAPEUTICS INC | $112,892,832 | +1636.4% | 3,940,413 | 0.0% | 7.45% | +1734.7% | |
| BAM | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $82,088,918 | +14.1% | 2,508,830 | 0.0% | 5.42% | +20.6% | |
| CORT | CORCEPT THERAPEUTICS INC | $73,162,455 | +6.6% | 3,377,768 | 0.0% | 4.83% | +12.7% | |
| TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $66,116,756 | +24.9% | 710,780 | 0.0% | 4.36% | +31.9% | |
| CABO | CABLE ONE INC | $66,060,306 | -1.4% | 94,103 | 0.0% | 4.36% | +4.2% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $51,174,503 | +16.0% | 500,827 | 0.0% | 3.38% | +22.5% | |
| DISC MEDICINE, INC. | $49,600,959 | +6.5% | 2,340,772 | 0.0% | 3.27% | +12.6% | ||
| EWTX | EDGEWISE THERAPEUTICS INC | $40,498,259 | -25.4% | 6,071,703 | 0.0% | 2.67% | -21.2% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $40,454,316 | +23.2% | 1,684,193 | 0.0% | 2.67% | +30.2% | |
| FOLD | AMICUS THERAPEUTICS INC | $23,243,531 | -9.2% | 2,095,900 | 0.0% | 1.53% | -4.0% | |
| RPHM | RENEO PHARMACEUTICALS INC | $20,513,654 | +156.7% | 3,430,377 | 0.0% | 1.35% | +171.1% | |
| SILK | SILK RD MED INC | $10,780,745 | -26.0% | 275,511 | 0.0% | 0.71% | -21.8% | |
| ABCL | ABCELLERA BIOLOGICS INC | $8,496,939 | -25.6% | 1,126,915 | 0.0% | 0.56% | -21.3% | |
| GRTX | GALERA THERAPEUTICS INC | $6,295,094 | +71.8% | 2,459,021 | 0.0% | 0.42% | +81.2% | |
| IO BIOTECH INC | $6,146,123 | -18.5% | 3,277,932 | 0.0% | 0.41% | -13.8% | ||
| LUNG | PULMONX CORP | $5,708,005 | +32.6% | 510,555 | 0.0% | 0.38% | +40.1% | |
| KNTE | KINNATE BIOPHARMA INC | $5,098,169 | +2.5% | 815,707 | 0.0% | 0.34% | +8.0% | |
| GLTO | GALECTO INC | $4,970,604 | +73.0% | 2,497,791 | 0.0% | 0.33% | +83.2% | |
| MQ | MARQETA INC | $2,017,920 | -25.2% | 441,558 | 0.0% | 0.13% | -20.8% | |
| SPRO | SPERO THERAPEUTICS INC | $679,908 | -16.2% | 468,902 | 0.0% | 0.04% | -11.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.